The Center for Wound Healing, Inc. Acquires Assets from Restorix Health
CFWH assumes management contracts and further strengthens foothold on the West Coast.
Tarrytown, NY (PRWEB) February 20, 2013
The Center for Wound Healing, Inc. (CFWH), a leading manager of comprehensive wound care treatment centers that offer advanced wound care and hyperbaric oxygen therapy, announces the acquisition of assets from Restorix Health, a Seattle-based company specializing in wound care management. Restorix offered full-service management programs that ensured maximization of current resources and infrastructure. Their three centers provide comprehensive wound care — specialized wound care and hyperbaric oxygen therapy — in Washington and California.
The acquisition supports CFWH´s vision to expand its best-in-class comprehensive wound care across the nation. “The acquisition of the Restorix centers is a perfect fit for our company,” explains Steve McLaughlin, CEO. “These centers are beautifully appointed and staffed.”
CFWH has assumed the management of the three centers — two are currently operational, with a third proceeding with construction.
About The Center for Wound Healing, Inc.
The Center for Wound Healing, Inc. is a leading manager of comprehensive wound care treatment centers that offer advanced wound care modalities as well as hyperbaric oxygen (“HBO”) therapy. The Company manages comprehensive wound care centers across the United States in partnership with local acute care hospitals. CFWH was founded by physicians in 1997 with a focus on establishing in-hospital centers of excellence to treat the growing incidence of severe grade diabetic wounds of the lower extremities and wounds that are unresponsive to general wound care treatments. The Company’s centers have consistently achieved high treatment success rates, resulting in a dramatic increase in patient quality of life and significant cost savings to the healthcare system. For more information, please visit our new website at http://www.centerwh.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10432935.htm